Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senju Wanhe Pharmaceutical (Liaoning) Co., Ltd. is a pharmaceutical joint venture established by Japan's Senju Pharmaceutical and China's Shenzhen Wanhe Pharmaceutical. Headquartered in the Liaoning Benxi High-tech Zone, the company specializes in the research, development, and manufacturing of ophthalmic medications for the Chinese market. Its product portfolio includes treatments for cataracts, allergic conjunctivitis, and inflammatory eye conditions, leveraging Senju's global expertise in eye care. The company operates a state-of-the-art manufacturing facility that adheres to international GMP standards. Senju Wanhe serves as a strategic hub for providing advanced ocular therapies to patients across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senju Wanhe Pharmaceutical.